Access Xenograft Data for Immunodeficient Models
May 8, 2012 - To help you select the most appropriate model for your in-house tumor xenograft studies, Charles River has published baseline xenograft data on the Athymic Nude, CB.17-SCID and SCID Hairless Outbred (SHO®) mice.
Graphs for tumor growth rates and standard agent efficacy are available in the following immunodeficient animal models.
CB.17-SCID (Strain Code 236)
Athymic Nude (Strain Code 490)
SCID Hairless Outbred (SHO®) (Strain Code 474)
Only available through Charles River, this hairless SCID can act as an alternative to the standard outbred nude, or as a cost-effective model for cell lines routinely grown in the standard congenic CB.17-SCID.
More xenograft data for other models will be published in the future as it is compiled. For more information about these data or any of our immunodeficient models, contact us at 1-877-CRIVER-1 or at email@example.com.
For more information, contact us at:
*indicates a required field.
The information you provided will be kept confidential.
Our study, presented at the 2013 Experimental Biology Conference, focuses on the phenotype and genotype comparison for C57BL/6N substrains contributing to the International Mouse Phenotyping Consortium (IMPC).
Clinical pathology data can assist you in selecting the most appropriate model for your study and can provide important information on the physiology and health of your research animals.
Jun 21–Jun 25
This five-day meeting draws diverse professionals from around the world to share their breakthroughs in the prevention, diagnosis and treatment of diabetes.
Jun 28–Jun 28
Charles River offers a wide range of seminars, workshops and training courses for animal technicians, veterinarians, biologists and laboratory technicians who work with laboratory animals. For more information about our course on animal health monitoring, click "view more" below.
This position is responsible for serving as a as a study director (SD), project scientist (PS) and/or principal investigator (PI) in the direction and execution of assigned studies in compliance with GLP regulations as they apply to the conduct of nonclinical research; coordinating all phases of the study planning process with appropriate departments; generating high-quality project plans, protocols, amendments and reports appropriate for assigned studies; reviewing, interpreting, integrating and presenting data on assigned studies; and functioning as contact for the planning and execution of sponsor interaction related to assigned studies, including proposal management and study scheduling, conduct and reporting.
This position is responsible for managing international aspects of US Federal income tax compliance; assisting with international tax planning, including identification of planning opportunities, designing and implementing plans, and transfer pricing process; overseeing quarterly ETR forecast process; and participating in the tax provision process, including assessment of tax risks, documentation of key positions, and review of non-US tax provision submissions.
Charles River Laboratories, Inc.